Last reviewed · How we verify

MIBOLERONE — Competitive Intelligence Brief

MIBOLERONE (MIBOLERONE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Other.

marketed Androgen receptor, Androgen receptor Other Small molecule Live · refreshed every 30 min

Target snapshot

MIBOLERONE (MIBOLERONE). Mibolerone works by binding to the androgen receptor, mimicking the effects of male hormones.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
MIBOLERONE TARGET MIBOLERONE marketed Androgen receptor, Androgen receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MIBOLERONE — Competitive Intelligence Brief. https://druglandscape.com/ci/mibolerone. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: